If you have to take a statin, you may be able to take a much lower dose if you take fish oil with it.
HDL is an important parameter of cardiovascular risk but many patients do not achieve HDL target values with a statin. In Clinical Lipidology, the effects of combined treatment with prescription omega-3 fatty acid ethyl esters plus escalating dosages (10, 20 and 40 mg/day) of atorvastatin on non-HDL-C and other lipid parameters were investigated in a 20-week, multicenter, double-blind, placebo-controlled study of patients with high non-HDL-C. Such a combination treatment reduced median non-HDL-C levels more than the treatment with atorvastatin alone but also caused a significant decrease of total cholesterol, VLDL-C and triglycerides and an increase in HDL-C and LDL-C, in the median percentage change from baseline.
When compared with the placebo group, a therapeutic approach that incorporates a combination of these drugs for atherogenic dyslipidemia treatment could be widely adopted to increase the number of patients that meet their non-HDL-C and other lipoprotein goals at lower medication doses.
No comments:
Post a Comment